NIH-funded research Career grant

Understanding how immune cells affect liver disease progression

Official title: Macrophage Mitochondrial Pyruvate Carrier in Nonalcoholic Steatohepatitis

Funded at Washington University · NIH-11058471 · Data updated 2026-11-12

This study is looking at how certain immune cells in the liver, called macrophages, change when someone has nonalcoholic steatohepatitis (NASH), a serious liver condition, to help find new ways to treat it and prevent complications.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startJuly 1, 2023
Project endMarch 31, 2028
Funding year2025
Award (this year)$134,376
NIH project number5K01DK137050-03
Project IDNIH-11058471 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with nonalcoholic steatohepatitis who are at risk for liver-related complications.

Less likely to help

Patients with liver diseases unrelated to nonalcoholic steatohepatitis may not benefit from this research.

What this research studies

This research focuses on nonalcoholic steatohepatitis (NASH), a serious liver disease that can lead to severe complications like cirrhosis and liver cancer. The study aims to explore the role of macrophages, a type of immune cell, in the progression of NASH by examining how these cells change their function and metabolism in response to liver damage. By identifying the mechanisms that influence macrophage behavior, the research seeks to uncover potential new treatments for NASH and its related health issues.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for treating nonalcoholic steatohepatitis and improving liver health.

How similar studies have gone: Previous research has shown promising results in understanding immune cell roles in liver diseases, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Ferguson, Daniel — Washington University
  • Study coordinator: Ferguson, Daniel

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.